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Environmental risk factors and their footprints in vivo – a proposal for the 
classification of oxidative stress biomarkers  
 
Pietro Ghezzi 




Environmental agents, including socioeconomic condition, and host factors can act as causal agents 
and risk factors in disease. We use biomarkers and sociomarkers to study causal factors, such as 
overproduction of reactive oxygen species (ROS) which could play a role in disease through oxidative 
stress. It is therefore important to define the exact meaning of the biomarker we measure. In this 
review we attempt a classification of biomarkers related to oxidative stress based on their biological 
meaning. We define as type zero biomarkers the direct measurement of ROS in vivo in patients. Type 
1 biomarkers are the most frequently used indicators of oxidative stress, represented by oxidized 
lipids, proteins or nucleic acids and their bases. Type 2 biomarkers are indicators of the activation of 
biochemical pathways that can lead to the formation of ROS. Type 3 biomarkers are host factors 
such as small-molecular weight antioxidants and antioxidant enzymes, while type 4 biomarkers 
measure genetic factors and mutations that could modify the susceptibility of an individual to 
oxidative stress. We also discuss whether biomarkers are actionable or not, that is if the specific 
blockade of these molecules can ameliorate disease or if they are just surrogate markers. 
The proposed classification of biomarkers of oxidative stress based on their meaning and 
ambiguities, within the theoretical framework of the oxidative stress theory of disease may help 
identify those diseases, and individuals, where oxidative stress has a causal role, to allow targeted 
therapy and personalized medicine. 
 
Introduction 
Oxidative stress (OS) is considered a potential mechanism in the toxicity of several chemicals as well 
as in the aetiology of many diseases, where its causal role is often implied by the suggestion, 
frequently made in the literature, that antioxidant molecules could have a protective effect in those 
conditions. 
In the following pages we will discuss the different positions of oxidative stress in the theoretical 
frameworks of disease causation, and how the different roles of oxidative stress can be studied using 
biomarkers. We will first summarize some basic concepts of causation. Then we will provide some 
examples of the causal role of oxidative stress in toxicology and in the aetiology of several diseases, 
giving some consideration to the concept of risk factor and the use of biological responses as 
biomarkers. In this context, we will focus on biomarkers used in human studies. Finally, we will 
discuss the problem of psychological stress and socioeconomic conditions (and sociomarkers) as an 
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often overlooked component of the causal framework. We will conclude with some considerations 
on biomarker classification with respect to their actionability. 
 
1. Causation in medicine  
The modern concept of multiple causation in disease is well represented in the scheme described by 
Rothman [1] and shown in Fig. 1A. According to this model, a disease can be caused by several 
different sufficient causes (Rothman’s pies), each composed of different component causes (the 
slices). Hence, a component cause (e.g. oxidative stress) could be a slice in the pie and, while not 
causing the disease alone, could do so in combination with other component causes. The limitation 
of the pie scheme is that it doesn’t distinguish risk factors (such as crowding or immunosuppression, 
in the case of tuberculosis) and essential component causes (such as the presence of mycobacteria, 
in the case of tuberculosis).  
According to the World Health Organization, “A risk factor is any attribute, characteristic or exposure 
of an individual that increases the likelihood of developing a disease or injury. Some examples of the 
more important risk factors are underweight, unsafe sex, high blood pressure, tobacco and alcohol 
consumption, and unsafe water, sanitation and hygiene.” 
(https://www.who.int/topics/risk_factors/en/). The definition is, in reality, more complex, and a risk 
factor may be considered as such if it associated with an increased risk of disease but may not be, in 
itself, a cause. 
Oxidative stress could participate in the causation of disease in three ways: 1) as a sufficient cause 
(when oxidative stress alone can induce the disease); 2) as insufficient but necessary component 
cause (oxidative stress will induce the disease only when combined with other component causes 
but, whatever the combination of causes is, oxidative stress has to be present); 3) as a non-
necessary component cause (that is, in some patients oxidative stress will contribute in the disease 
but other patients may develop the same condition with a different set of component causes, even 
in the absence of oxidative stress). We have discussed elsewhere the implications of this model in 
determining the causal role of oxidative stress in disease and its therapeutic implications [2, 3]. 
Considering the topic of this special issue, another limitation of the two-dimensional pie model is 
that it does not distinguish host factors (such as genetic risk factors, for instance lower levels of an 
antioxidant enzyme) and environmental factors. 
Two other schemes could be useful here, representing two different views of the epidemiological 
triad in disease causation (Fig. 1B and C). This triad is typically used to represent causation in 
infectious disease. However, its use has been proposed in the interpretation of non-infectious 
conditions, such as injury [4] and diabetes [5]. 
We will try here to consider the relative role of oxidative stress as an agent, as part of the 
environmental component,s and as a host factor, and will provide examples based on the use of 
biomarkers to detect its various roles as a slice of causal pies or element in the causative triad, 
focusing on clinical data.  
A prerequisite for the hypothesis of a causal role of oxidative stress in disease is the measurement of 
markers of oxidative stress in patients, and this review will discuss the differences between the 
various biomarkers of oxidative stress. However, it is important to distinguish between association 
and causation [6-8]. Specifically, the association of oxidative stress and disease (statistical 
association) could be explained not only by hypothesizing that oxidative stress causes the disease 
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but also that it is the disease that causes oxidative stress (reverse causation) [9, 10]. It is also 
possible that both the disease and oxidative stress are caused by a third factor (confounder); for 
instance, in an inflammatory disease, inflammation could cause both the disease and oxidative stress 
(such as through ROS production by phagocytes) [9, 10]. While this has already been discussed 
elsewhere, this has to be kept in mind when considering the use of biomarkers either as 
prognostic/diagnostic indicators or in the formulation of causal theories. 
 
2. Oxidative stress biomarkers 
Oxidative stress is an expression used to define a status where the levels or ROS are increased, 
either due to increased production or impairment in the antioxidant systems [11]. However, the 
short half-life of ROS makes it very difficult to measure them in biological samples obtained from 
patients. It should be mentioned that there are a number of methodologies developed for 
measuring ROS directly, despite of their short half-lives, as mentioned in section 4.2. However, while 
they have been widely applied to in vitro or animal studies, they are not yet easily applicable to 
patients. For this reason, oxidative stress is usually assessed by measuring the products of the 
oxidation of cellular molecules by ROS in blood, urine or exhaled breath, depending on the 
biomarker (reviewed in [12, 13]). These include biomarkers of lipid oxidation (such as 
malondialdehyde, MDA, or isoprostanes), protein oxidation (particularly protein carbonyls) and 
nucleic acid oxidation (particularly 8-hydroxydeoxyguanosine, 8-OH-dG). This is an important 
limitation as ROS, particularly H2O2, are also important signalling molecules. Thus, it could be argued 
that by measuring only terminal product of oxidation reactions we detect “oxidative damage” rather 
than “oxidative stress”. 
 
3. Oxidative stress as a causal factor. 
We will examine here the cases where oxidative stress was suggested to act as the main, essential 
and sufficient, cause of disease. In our view, the only such examples are in the field of toxicology, 
namely the toxicity of the herbicide paraquat, hyperoxia, and ionizing radiation. 
 
3.1. Paraquat 
Paraquat (1,1′-dimethyl-4,4′-bipyridylium dichloride) is an herbicide that causes a significant number 
of deaths by pulmonary toxicity, due to its accumulation in the lung. The mechanism of toxicity has 
been well studied and is related to generation of ROS though redox cycling catalyzed by several 
oxidases (reviewed in [14]). Although this has been extensively studied in animal models, there is 
also evidence that paraquat poisoning is associated with increased biomarkers of oxidative stress in 
patients. Dinis-Oliveira et al. [14] have reviewed the studies on biomarkers of oxidative stress in 
paraquat-poisoned patients, and concluded that lipid peroxidation has been detected in studies on a 
few patients, either as serum malondialdehyde (MDA) levels or exhaled ethane. 
 
3.2. Ionizing radiations 
Ionizing radiations have long been known to generate ROS [15], and pulse radiolysis has been, 
historically, a means of generating superoxide radicals in vitro [16]. The efficacy of thiols as 
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radioprotectant demonstrates a causative role for ROS in radiation-induced DNA damage [17]. 
Despite this, the few published studies in patients showed that radiotherapy results only in a small 
increase in serum MDA levels [18, 19]. Indirect evidence for an increase in plasma hydroperoxides 
(measured by chemiluminescence or as conjugated dienes) was observed in workers involved in the 
clean-up following the Chernobyl accident who suffered from post-radiation syndrome [20, 21]. 
 
3.3. Oxygen toxicity 
Oxygen toxicity, such as that following exposure to hyperbaric oxygen, is also thought to be in part 
due to increased ROS formation with a mechanism similar to radiation toxicity [22]. However, the 
literature report contradictory results. Some studies reported that exposure of patients to 
hyperbaric oxygen increases levels of blood lipid hydroperoxides [23], MDA [24] and 8-isoprostane 
[25], while other studies showed a very small effect or no effect on these markers [26, 27]. 
 
3.4. Oxidative stress following exposure to environmental chemicals and stressors 
Several studies have measured markers of oxidative stress in relation to environmental chemicals. 
For instance, MDA levels in exhaled breath condensate was associated with air pollution in a study in 
Bejing [28] and in workers exposed to titanium dioxide nanoparticles [29]. A meta-analysis of over 50 
studies has reached the conclusion that exposure to combustion particles due to air pollution 
(excluding occupational health) is associated with increased levels of biomarkers of DNA oxidation 
(such as 8-oxo-7,8-dihydroguanine or 8-oxo-7,8-dihydro-2´-deoxyguanosine) or of lipid oxidation 
(including MDA and isoprostanes) [30]. More specifically, a meta-analysis of studies using F2-
isoprostane as a biomarker of oxidative stress has found a significant effect of exposure to asbestos, 
occupational exposure and silicosis [31].  It is important to note that these studies reported an 
association, and did not attempt to establish whether oxidative stress had a causal role in the 
mechanism of toxicity of xenobiotics or if it was associated with the severity of the toxic effects. 
Finally, non-chemical environmental stressors can also be associated with oxidative stress, and 
increased biomarkers of oxidative stress in response to environmental noise could shed light on 
epidemiological evidence that traffic noise is associated with cardiovascular disease [32, 33].  
 
4. Oxidative stress as a causal component or risk factor in disease 
Oxidative stress has been suggested as a causal component for almost any disease, and different 
expressions have been used for this in the literature, such as: plays a role, is important for, is 
implicated etc.  A recent comprehensive meta-analysis summarizing the evidence for an increase in 
the levels of the lipid peroxidation products F2-isoprostane in disease lists about 50 different disease 
conditions [31].  
 
4.1. The “redox status” as a causal component or a risk factor 
As mentioned above, it is not easy to distinguish a risk factor from a component cause for a disease. 
We can assume, although not with an absolute certainty, that oxidative stress is a cause, and 
probably a sufficient cause, of paraquat toxicity. However, the role of oxidative stress in disease is 
more complex. We searched the Web of Science on 23/10/2018 for “oxidative stress meta-analysis 
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OR oxidative stress metaanalysis”. The aim of the search was to find all studies where one or more 
oxidative stress-related biomarkers were measured in patients with specific disease conditions 
compared to healthy controls. After excluding interventional studies we analyzed 198 studies. The 
“biomarkers” measured, which were used to conclude (or exclude) an association between disease 
and oxidative stress, are listed in Fig. 2.  
We can classify these in four types of biomarkers. The first type, that we and others defined as 
“biomarkers of oxidative stress”, are, in fact, biomarkers of “oxidative damage” as discussed in 
section 2, and include the oxidation products of lipid, proteins and nucleic acids. This group also 
includes molecules that are decreased following oxidation by ROS, such as glutathione (GSH).  
A second type of biomarkers are indicators that ROS-generating enzymes have been activated. To 
our knowledge, the only biomarkers of this type are uric acid (UA) and allantoin, stable products of 
ROS-generating xanthine oxidase (XO). They also include hypochlorous acid (HOCl) that is an 
indicator of phagocytic H2O2 production via myeloperoxidase [34, 35]. 
A third type are biomarkers measuring factors that determine the susceptibility to oxidative damage. 
We include in this group enzymes (such as superoxide dismutase, SOD, or catalase, CAT) and small-
molecular weight molecules (e.g. vitamins C and E, bilirubin) that react with ROS and are often 
generically described as antioxidants or scavenges. This group also includes levels of enzymes that 
produce ROS (e.g. NADPH oxidases, NOX, and   XO). 
Finally, as this review focusses on biomarkers used to study causative mechanisms, we included a 
fourth type of biomarkers represented by the measure of mutations in the various enzymes 
implicated as ROS producers or scavengers, as they will provide information on the host factors 
determining the susceptibility to an environmental stressor, and thus indicate a role for oxidative 
stress in a specific disease. For instance,  the association between mutations of the SOD2 gene and 
the risk of diabetes [36], or that of mutations in the gene encoding for Nrf2 with Parkinson’s disease 
[37] could support the hypothesis that oxidative stress is somewhat implicated in these diseases. 
To be clear, one would expect that if we induce oxidative stress, for instance with paraquat, the 
levels of the first type of biomarkers will increase (or decrease in the case of GSH) but the level of 
risk factors will not change, at least in the early phases of intoxication (it may increase later as an 
adaptive response, as we will discuss in section 4.2 below). On the other hand, the levels of risk 
factors pre-existing paraquat exposure can be important in determining the susceptibility to the 
oxidative stress-mediated toxic action of paraquat, and the same will be true for genetic factors. 
In essence, type 3 and 4 biomarkers are not part of the exposome as they are not affected by 
oxidative stress, but rather host factors. Of course, what we are missing in clinical studies are “type 
zero” biomarkers, that is a direct, unambiguous, measurement of ROS in patients. However, imaging 
techniques have been developed that may allow this in the near future [38, 39]. 
Of note, some of these biomarkers are ambiguous and can belong to more than one classification. 
For instance decreased levels of GSH can be a sign of oxidative stress as GSH is oxidized by H2O2. 
However, low pre-exposure levels of GSH in an individual can increase the susceptibility to oxidative 
stress-mediated injury. High levels of UA can be a marker positively associated with oxidative stress 
as it is an indicator of the activation of ROS-producing xanthine oxidase. However, UA is also an 




4.2. Adaptive response as a biomarker: nuclear factor (erythroid-derived 2)-like2 (Nrf2) and the 
antioxidant/electrophile response 
There is an important caveat to our last paragraph. In fact, exposure to a xenobiotic that induces 
oxidative stress, or that is a direct electrophile, will result in an adaptive response mediated by the 
activation of Nrf2 through oxidation of its redox- and electrophile-sensor, Keap1 (reviewed in [41]) 
and consequently increase the levels of its target genes including the GSH synthetic enzyme 
glutamate-cysteine ligase, NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), superoxide 
dismutase (SOD) and thioredoxin. 
This highlights the possible use of biomarkers of response as an indication that oxidative stress has 
taken place. It is not unusual to assess a secondary biological response as an indicator of the 
activation of a causal mechanism in disease. As we noted elsewhere [3], the most used biomarker of 
inflammation is not represented by inflammatory cytokines (that have a causal role in the disease) 
but by C-reactive protein (CRP), whose production in the liver is increased as a secondary effect of 
the cytokine interleukin 6 (IL-6).  
Measuring a biological response to oxidative stress can have the advantage or offering biomarkers 
with a more favourable kinetics over biomarkers of oxidative stress (our type 1) and would have the 
added value of measuring an occurrence of oxidative stress that has been biologically relevant. On 
the other hand, biomarkers of Nrf2 activation are also ambiguous because not only they are 
indicators of oxidative stress but they also behave as protective factors that detoxify ROS (negative 
risk factors). 
These types of biomarkers are already being used in environmental toxicology. For instance, 
activation of Nrf2 has been reported in fish treated with environmental pollutants [42, 43], and a 
study on over 500 women has found an association between the expression of Nrf2 target genes and 
the level of exposure to biomass fuel smoke [44]. The Keap1-Nrf2 redox sensor is of particular 
importance in the context of environmental chemicals as it regulates several pathways implicated in 
the detoxification of xenobiotics. Finally, there are other biological responses that can help detect 
oxidative stress, such as changes in the circadian clock [45]. 
It is important to note a limitation in the use of Nrf2 as a biomarker of oxidative stress when 
studying its association with a disease. In fact, while Nrf2 activation is an indicator of oxidative 
stress, and thus might correlate with disease severity, it also reflect an adaptive-protective response 
and thus negatively correlate with disease severity. Its meaning is, therefore, ambiguous. 
 
5. Role of psychosocial factors and sociomarkers. 
We often consider social and psychological factors as additional variables, independent of strictly 
biological ones like oxidative stress. However, it is probably wrong to see those as independent. The 
problem of the social determinants of health has been well summarized in 2005 by Marmot [46]. 
Socioeconomic factors not only affect health through differences in the access to healthcare but an 
integrated framework has also been proposed where socioeconomic factors influence health 
through psychosocial factors such as health behaviours and stress [47, 48]. 
Studies have shown that lower education levels are associated with higher levels of inflammatory 
biomarkers, lower GSH levels [49] and higher isoprostanes levels [50] [51]. Women under financial 
strain have higher serum protein carbonyl levels [52].  Biomarkers of oxidative stress are also 
elevated in conditions of adverse childhood experiences [53, 54], with increased perceived workload 
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[55] and in victims of violence against women [56]. Finally, there is an abundant literature on 
oxidative stress in psychiatric disorders (see for instance [57-59] although, as usual, it is unclear 
whether this is a cause or a consequence of the disease. 
These findings have led to definition of “sociomarkers” as recently defined by Ghiara and Russo [60]. 
Researchers are starting considering the correlations of sociomarkers with mechanisms of disease 
such as inflammation [61] and the use of sociomarkers, along with biomarkers, as prognostic 
indicators, for instance in asthma [62]. We could make many hypotheses on how social markers 
could induce oxidative stress. This could be in part due to psychological stress, and there are studies 
showing that stress hormones, particularly glucocorticoids, induce oxidative stress [63, 64]. 
Socioeconomic factors are also associated with health behaviours such as smoking, lower exercise 
and unhealthy diet with consequent obesity [65, 66], all of whom may impact on oxidative stress. 
However, sociomarkers should be considered not only as surrogate markers of health behaviour 
(such as dietary habits and malnutrition) but also as an integral part of the causal pathways by which 
environmental factors affect health.  In fact, in addition to factors such as stress due to adverse 
childhood experiences [67-69], socioeconomic status may affect access to healthcare [70], and this 
may be particularly important for psychiatric disorders [71].  
 
6. Actionability of biomarkers 
As we noted elsewhere, some biomarkers measure molecules that are in the causal pathway of 
disease [3, 72]. For instance, in the case of inflammatory diseases, inflammatory cytokines such as IL-
6 are not only indicators of inflammation but also pharmacological targets and blocking IL-6, for 
instance with antibodies, will improve the disease [73]. Other biomarkers of inflammation, such as 
CRP, are clinically recognized as better diagnostic biomarkers, but blocking them will not ameliorate 
disease because they are not involved in the causal pathways.  We could then say that IL-6 is an 
actionable biomarker, while CRP is not. 
The problem with oxidative stress biomarkers is that few of them have a role as causal components 
of disease. The oxidative stress theory of disease implies ROS as the noxious agent. However, ROS 
have an extremely short half-life making their measurements in patients very difficult, it very 
difficult, at least with the existing technologies. We therefore resort to measure non-actionable 
biomarkers such as the end products of their reaction with biological molecules. There is a caveat to 
this, however, as some of the terminal products of lipid peroxidation, typically aldehydes, can have 
toxic properties and/or react with proteins to produce protein carbonyls (e.g. HNE) [74].  
 
Conclusions 
The scheme in Fig. 3 shows how we could fit the biomarkers as classified in Fig. 2 in the causal 
hypothesis where ROS are a component cause in disease. We suggest that the different role of 
biomarkers in the causal pathway as well as their actionability should be taken into account when 
attempting to draw the big picture of biomarkers of oxidative stress in relation to the exposome.  
The proposed classification of biomarkers of oxidative stress is not just an attempt to build a 
theoretical framework but could help in making conclusions on the causal role of oxidative stress in 
disease. In fact, if different biomarkers have different meanings, it would then be important to 
distinguish, for instance, indicators that oxidative stress has occurred from risk factors. This would 
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also be important in meta-analyses, where only biomarkers with the same meaning should be 
analyzed together. 
A classification of biomarkers could also be useful when considering the different use of biomarkers. 
While this reviews has focused on their importance when studying the causal mechanism of the 
disease, biomarkers are also used for diagnostic or prognostic purposes. We discuss elsewhere the 
possibility that, when oxidative stress is not a cause of a disease but its consequence, biomarkers 
showing evidence of oxidative stress (indicated as type 1 or type 0 here), could be used as surrogate 
markers of disease [9]. The challenge for the future will be to extend the research on the role of 
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Figure 1. Models of disease causation. 
A The Rothman pie [1]. B, C The epidemiological triad. From  Centers for Disease Control and 
Prevention [Internet]. Atlanta. https://www.cdc.gov/csels/dsepd/ss1978/lesson1/section8.html 
(public domain). 
 
Figure 2. Biomarkers related to oxidative stress and their meaning 
Abbreviations used: CAT, catalase; DUOX, dual oxidase; GPX, GSH peroxidase; GSH, glutathione; 
HNE, hydroxynonenal; IMA, ischemia-modified albumin; MPO, myeloperoxidase; PON1, paraoxonase 
1 UA, uric acid; Vit, vitamin. 
 
Figure 3. The oxidative stress theory of disease. Participating factors and their biomarkers. 
Image sources (CC BY-SA 3.0): 
https://commons.wikimedia.org/wiki/File:Double_stranded_DNA_with_coloured_bases.png,  
https://commons.wikimedia.org/wiki/File:Protein_PCMT1_PDB_1i1n.png 
https://commons.wikimedia.org/wiki/File:Lipid_bilayer_and_micelle.svg  
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